Abstract
Prostate cancer is one of the main causes of cancer death, and drug resistance is the leading reason for therapy failure. However, how this occurs is largely unknown. We therrfore aimed to study the response of DU145 cells to cisplatin. Du145 prostate cancer cells were treated with a low dose of cisplatin for 24 h and cell viability and number were determined by MTT assay and trypan blue exclusion assay, respectively. The real time polymerase chain reaction (PCR) was used to assess responses to cisplatin treatment. After 24h 2 μg/ml treatment did not result in significant reduction in cell viability or number. However, it led to enhanced cancer cell invasiveness. E-cadherin mRNA was reduced, and vimentin, Snail, Slug, metalloproteinase 9 (MMP9) mRNA expression increased significantly, a feature of epithelial-mesenchymal transition (EMT). Short time low concentration cisplatin treatment leads to elevated invasiveness of DU145 cancer cells and this is possibly due to EMT.
References
May 12, 1989·Journal of Immunological Methods·M B HansenK Berg
Nov 28, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anthony V D'AmicoDelray Schultz
Oct 25, 2003·Oncogene·Zahid H Siddik
Jul 13, 2007·Nature Reviews. Cancer·Lloyd Kelland
Apr 15, 2008·Trends in Molecular Medicine·Nancy Gavert, Avri Ben-Ze'ev
Feb 25, 2009·Nucleic Acids Research·J M RuijterA F M Moorman
Jun 3, 2009·The Journal of Clinical Investigation·Raghu Kalluri, Robert A Weinberg
Mar 9, 2010·Journal of Biomolecular Screening·Patrick Y K YueRicky N S Wong
May 28, 2011·Journal of Cellular Biochemistry·Ardian LatifiNuzhat Ahmed
Jul 14, 2012·Cell Stress & Chaperones·B J LangJohn T Price
Oct 12, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Rongfei HanQiuping Zhang
Apr 25, 2013·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Kyu-Won JungJin-Soo Lee
Jan 1, 2011·Cancers·Ana-Maria Florea, Dietrich Büsselberg
Jan 9, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Jan 28, 2014·PloS One·Sébastien BaribeauÉric Asselin
Jun 18, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Rong-Fei HanQiu-Ping Zhang
Aug 2, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Ling-Bin DuWei-Min Mao
Citations
Mar 22, 2018·Oncotarget·Pengming SunJalid Sehouli
Jun 7, 2020·International Journal of Molecular Sciences·Milad AshrafizadehGautam Sethi
Oct 6, 2020·Journal of Oncology·Shi-Feng XuYun-Jin Zang
Dec 30, 2016·Archives of Toxicology·Anamaria Brozovic
Nov 21, 2019·International Journal of Oncology·Annie Riera LealAna Laura Pereira-Suárez
Jul 3, 2021·Biomolecules·Jingjing ShaTakahiro Kanno
Aug 8, 2021·International Journal of Molecular Sciences·Hyeong Sim ChoiPil-Young Yun